Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter May 28, 2018

Analytical performance of the single well titer function of NOVA View®: good enough to omit ANA IIF titer analysis?

Lieve Van Hoovels, Sofie Schouwers, Stefanie Van den Bremt, Laura Bogaert, Nathalie Vandeputte, Martine Vercammen and Xavier Bossuyt

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Solomon DH, Kavanaugh AJ, Schur PH, American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheumatol 2002;47:434–44.10.1002/art.10561Search in Google Scholar

2. Meroni PL, Schur PH. ANA screening: an old test with new recommendations. Ann Rheum Dis 2010;69:1420–2.10.1136/ard.2009.127100Search in Google Scholar

3. Agmon-Levin N, Damoiseaux J, Kallenberg C, Sack U, Witte T, Herold M, et al. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis 2014;73:17–23.10.1136/annrheumdis-2013-203863Search in Google Scholar

4. Chan EK, Damoiseaux J, de Melo Cruvinel W, Carballo OG, Conrad K, Francescantonio PL, et al. Report on the second International Consensus on ANA Pattern (ICAP) workshop in Dresden 2015. Lupus 2016;25:797–804.10.1177/0961203316640920Search in Google Scholar

5. Bizzaro N, Antico A, Platzgummer S, Tonutti E, Bassetti D, Pesente F, et al. Automated antinuclear immunofluorescence antibody screening: a comparative study of six computer-aided diagnostic systems. Autoimmun Rev 2014;13:292–8.10.1016/j.autrev.2013.10.015Search in Google Scholar

6. Van den Bremt S, Schouwers S, Van Blerk M, Van Hoovels L. ANA IIF automation: moving towards harmonization? Results of a multicenter study. J Immunol Res 2017;2017:6038137.10.1155/2017/6038137Search in Google Scholar

7. Schouwers S, Bonnet M, Verschueren P, Westhovens R, Blockmans D, Mariën G, et al. Value-added reporting of antinuclear antibody testing by automated indirect immunofluorescence analysis. Clin Chem Lab Med 2014;52:547–51.10.1515/cclm-2013-0610Search in Google Scholar

8. Oyaert M, Bossuyt X, Ravelingien I, Van Hoovels L. Added value of indirect immunofluorescence intensity of automated antinuclear antibody testing in a secondary hospital setting. Clin Chem Lab Med 2016;54:e63–6.10.1515/cclm-2015-0887Search in Google Scholar

9. Bossuyt X, Cooreman S, De Baere H, Verschueren P, Westhovens R, Blockmans D, et al. Detection of antinuclear antibodies by automated indirect immunofluorescence analysis. Clin Chim Acta 2013;415:101–6.10.1016/j.cca.2012.09.021Search in Google Scholar


Supplementary Material:

This article contains supplementary material (https://doi.org/10.1515/cclm-2018-0338).


Received: 2018-04-02
Accepted: 2018-04-23
Published Online: 2018-05-28
Published in Print: 2018-10-25

©2018 Walter de Gruyter GmbH, Berlin/Boston